Literature DB >> 3336415

Decreased catecholamines in the adrenal medulla of patients with parkinsonism.

S W Carmichael, R J Wilson, W S Brimijoin, L J Melton, H Okazaki, T L Yaksh, J E Ahlskog, S L Stoddard, G M Tyce.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3336415     DOI： 10.1056/NEJM198801283180415

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

Authors:  M Gerlach; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

2.  Cardiac sympathetic denervation preceding motor signs in Parkinson disease.

Authors:  David S Goldstein; Yehonatan Sharabi; Barbara I Karp; Oladi Bentho; Ahmed Saleem; Karel Pacak; Graeme Eisenhofer
Journal:  Clin Auton Res       Date:  2007-03-02       Impact factor: 4.435

Review 3.  Neuropathology in movement disorders.

Authors:  W R Gibb
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

Review 4.  Autonomic nervous system and risk factors for vascular disease. Effects of autonomic unbalance in schizophrenia and Parkinson's disease.

Authors:  Giulio Scigliano; Gabriele Ronchetti; Floriano Girotti
Journal:  Neurol Sci       Date:  2008-04-01       Impact factor: 3.307

Review 5.  Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis.

Authors:  Emanuele Cereda; Michela Barichella; Carlo Pedrolli; Catherine Klersy; Erica Cassani; Riccardo Caccialanza; Gianni Pezzoli
Journal:  Diabetes Care       Date:  2011-12       Impact factor: 19.112

6.  Cardiac sympathetic denervation in 6-OHDA-treated nonhuman primates.

Authors:  Valerie Joers; Kristine Dilley; Shahrose Rahman; Corinne Jones; Jeanette Shultz; Heather Simmons; Marina E Emborg
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

7.  Lipid-lowering drug targets and Parkinson's disease: A sex-specific Mendelian randomization study.

Authors:  Yangfan Zhao; Sarah A Gagliano Taliun
Journal:  Front Neurol       Date:  2022-09-01       Impact factor: 4.086
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.